INGENOL MEBUTATE

SynDRA canonical compound SYN0027909 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Primary target(s)	PRKCA \| PRKCB \| PRKCD \| PRKCE \| PRKCG
Mechanism of action	PKC activator
Indication	actinic keratosis (AK)
Disease area	dermatology

All known targets

picato
PEP005
Ingenol 3-angelate
3-Angeloylingenol
3-Ingenyl angelate
Mebutate d'ingenol
Mebutato de ingenol
AGN 204332
AGN204332
PEP-005
Picato
Ingenol-3- angelate
PEP 005
UNII-7686S50JAH
7686S50JAH
Picato (TN)
Euphorbia factor H1
Euphorbia factor An1
Ingenol mebutate [USAN:INN]
[dihydroxy-(hydroxymethyl)-tetramethyl-oxo-[ ]yl] (Z)-2-methylbut-2-enoate
I3A
Ingenol mebutate (USAN)
(Z)-2-methylbut-2-enoate
SCHEMBL2526605
GTPL7443
CHEMBL1863513
HSDB 8308
VDJHFHXMUKFKET-WDUFCVPESA-N
MolPort-003-941-761
AN-262
POL-103A
ingenol.mebutate
ingenol-mebutate
Ingenol-3-angelate
Ingenol mebutate [USAN]
(1aR,2S,5R,5aS,6S,8aS,9R,10aR)-5,5a-dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1a,2,5,5a,6,9,10,10a-octahydro-1H-2,8a-methanocyclopenta[a]cyclopropa[E][10]annulen-6-yl (2Z)-2-methylbut-2-enoate
C25H34O6
2-Butenoic acid, 2-methyl-, (1aR,2S,5R,5aS,6S,8aS,9R,10aR)-1a,2,5,5a,6,9,10,10a-octahydro-5,5a-dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1H-2,8a-methanocyclopenta(a)cyclopropa(e)cyclodecen-6-yl ester, (2Z)-